The effectiveness of intratympanic injections with methylPREDnisolon versus placebo in the treatment of vertigo attacks in MENière's disease (PREDMEN trial): a study protocol for a phase-3 multicentre, double-blinded, randomised, placebo-controlled trial.

MLA

Boreel, Maud Martina Emilie, et al. “The Effectiveness of Intratympanic Injections with MethylPREDnisolon versus Placebo in the Treatment of Vertigo Attacks in MENière’s Disease (PREDMEN Trial): A Study Protocol for a Phase-3 Multicentre, Double-Blinded, Randomised, Placebo-Controlled Trial.” BMJ Open, vol. 14, no. 8, Aug. 2024, p. e076872. EBSCOhost, https://doi.org/10.1136/bmjopen-2023-076872.

APA

Boreel, M. M. E., van Esch, B., Schermer, T. R., Mol, B. M., van Benthem, P. P., & Bruintjes, T. D. (2024). The effectiveness of intratympanic injections with methylPREDnisolon versus placebo in the treatment of vertigo attacks in MENière’s disease (PREDMEN trial): a study protocol for a phase-3 multicentre, double-blinded, randomised, placebo-controlled trial. BMJ Open, 14(8), e076872. https://doi.org/10.1136/bmjopen-2023-076872

Chicago

Boreel, Maud Martina Emilie, Babette van Esch, Tjard R Schermer, Berber M Mol, Peter Paul van Benthem, and Tjasse D Bruintjes. 2024. “The Effectiveness of Intratympanic Injections with MethylPREDnisolon versus Placebo in the Treatment of Vertigo Attacks in MENière’s Disease (PREDMEN Trial): A Study Protocol for a Phase-3 Multicentre, Double-Blinded, Randomised, Placebo-Controlled Trial.” BMJ Open 14 (8): e076872. doi:10.1136/bmjopen-2023-076872.